O. Fain

Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*

Sophie Georgin‐Lavialle, Benjamin Terrier, Alexis F. Guédon et al. · British Journal of Dermatology · 2021 · 387 citations · Full text

High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody

Yves Allenbach, Jérémy Keraen, Anne‐Marie Bouvier et al. · Brain · 2016 · 263 citations · Full text

Immunology, Pathology, Immunotherapy +17

Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment

Rakiba Belkhir, S. Le Burel, Laetitia Dunogeant et al. · Annals of the Rheumatic Diseases · 2017 · 238 citations

Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis

S. Le Burel, Stéphane Champiat, Christine Mateus et al. · European Journal of Cancer · 2017 · 196 citations

Inflammation, Autoimmune Disease, Immunotoxicology +7

Lack of Superiority of Steroids Plus Plasma Exchange to Steroids Alone in the Treatment of Polyarteritis Nodosa and Churg‐Strauss Syndrome

O. Fain, François Lhote, B Jarrousse et al. · Arthritis & Rheumatism · 1992 · 172 citations